Journal article icon

Journal article

Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule.

Abstract:
Molecules that alter the normal dynamics of microtubule assembly and disassembly include many anticancer drugs in clinical use. So far all such therapeutics target β-tubulin, and structural biology has explained the basis of their action and permitted design of new drugs. However, by shifting the profile of β-tubulin isoforms, cancer cells become resistant to treatment. Compounds that bind to α-tubulin are less well characterized and unexploited. The natural product pironetin is known to bind to α-tubulin and is a potent inhibitor of microtubule polymerization. Previous reports had identified that pironetin reacts with lysine-352 residue however analogues designed on this model had much lower potency, which was difficult to explain, hindering further development. We report crystallographic and mass spectrometric data that reveal that pironetin forms a covalent bond to cysteine-316 in α-tubulin via a Michael addition reaction. These data provide a basis for the rational design of α-tubulin targeting chemotherapeutics.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1038/ncomms12103

Authors


Royal Society More from this funder
Grant:
Wolfson Merit Award
Wellcome Trust Senior Investigator Award More from this funder
Grant:
WT100209MA
Sichuan Province Thousand Talents Scheme More from this funder
State Key Program of National Natural Science of China More from this funder
Chinese National Thousand Talents Program More from this funder


Publisher:
Nature Publishing Group
Journal:
Nature Communications More from this journal
Volume:
7
Pages:
12103
Publication date:
2017-06-01
Acceptance date:
2016-05-27
DOI:
EISSN:
2041-1723


Language:
English
Keywords:
Pubs id:
pubs:699015
UUID:
uuid:2e9eef89-b47c-4324-88c7-4af475b8aa8e
Local pid:
pubs:699015
Source identifiers:
699015
Deposit date:
2017-07-13
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP